Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189436
Status:
COMPLETED
Last Update Posted:
2021-02-01
First Post:
2005-09-12
Brief Title:
Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children
Sponsor:
Deborah Gentile
Organization:
West Penn Allegheny Health System
Study Overview
Official Title:
A Pilot Study to Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Pediatric Patients Following Discharge From the Emergency DepartmentOutpatient Care Facility
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BudER
Brief Summary:
Subjects aged 1-8 years who have been discharged from the emergency departmentoutpatient care facility with a diagnosis of asthmabronchospasmwheezing after usual standard care will be enrolled into this open-label randomized parallel-group study to compare the efficacy of nebulized budesonide and oral corticosteroids in preventing asthma exacerbation relapse rates during the 21-day follow-up period
Detailed Description:
Secondary outcomes include urinary cortisol-creatinine rations symptom severity scores and peak flow rates
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RC - 3425 | OTHER | InstitutionalAllegheny Singer Research Institute | None |